Intranasal application of vesicular stomatitis virus (VSV) induces acute encephalitis characterized by a pronounced myeloid and T cell infiltrate. The role of distinct phagocytic populations on VSV encephalitis was therefore examined in this study. Ablation of peripheral macrophages did not impair VSV encephalitis or viral clearance from the brain, whereas, depletion of splenic marginal dendritic cells impaired this response and enhanced morbidity/mortality. Selective depletion of brain perivascular macrophages also suppressed this response without altering viral clearance. Thus, two anatomically distinct phagocytic populations regulate VSV encephalitis in a non-redundant fashion although neither population is essential for viral clearance in the CNS.
Introduction
Vesicular stomatitis virus (VSV) is a neurotrophic ssRNA virus of the Vesiculovirus genus in the Rhabdoviridae family and is the prototypic virus of this family that includes rabies virus. Following systemic infection, immunocompetent mice rapidly clear VSV from peripheral organs, produce IgM and neutralizing IgG antibodies and mount a robust CTL response although viral antigens persist for weeks in peripheral tissues. (Battegay et al., 1996; Charan et al., 1986; Turner et al., 2007) . When VSV is delivered via the intranasal route, it initially infects and replicates in olfactory receptor neurons and is then transmitted via the olfactory nerve to the central nervous system (CNS) within 12-24 h (Forger et al., 1991; Reiss et al., 1998) . VSV replicates invasively in the olfactory bulb (OB) penetrating deeper layers of this structure, reaching the OB ventricle by days 4-5 postinfection producing focal cytopathology. Depending on the dose and strain, virus can enter the ventricles causing inflammation and necrosis around the ventricles and travel caudally to the hindbrain by day 8 post-infection VSV does not use the trigeminal nerve for entry into the brain, as the trigeminal ganglion remains virus-free following intranasal infection. Although VSV infection of the CNS is associated with a high rate of morbidity and mortality, surviving mice completely clear infectious virus from the brain around days 10-12.
The observation that some mice survive CNS infection with this virus suggests that innate and adaptive antiviral mechanisms are activated in the CNS. With respect to innate immunity, prior immunohistochemical studies by Reiss et al. indicated that intranasal infection with VSV activated glial cells (astrocytes and microglia) initially in the OB and induced expansion of these resident cell populations (Bi et al., 1995) . Activation of astrocytes and microglia was likely responsible for the reported T cell-independent encephalitis seen with this virus (Frei et al., 1989; Nansen et al., 2000) . In addition to the innate response in the CNS, adaptive immunity also contributes to host resistance because SCID and nude mice invariably succumb to a fatal encephalitis but can be rescued by adoptively transferred T cells (Coons et al., 1991; Hummer et al., 1990) . Similarly, antibody-mediated depletion of CD8+ or CD4+ T cells renders mice susceptible to VSV replication and dissemination to the CNS (Huneycutt et al., 1993) . According to the current paradigm, T cells activated in the draining cervical lymph node (CLN) navigate through the blood brain barrier (BBB) to mediate their antiviral effector functions. Although the precise mechanism(s) by which T cells Journal of Neuroimmunology 226 (2010) [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] 
